CSVAX Performance — Columbia International Dividend Income Fund, Class A
Data updated: 2026-07-29
CSVAX returned +16.17% year to date and +33.35% over one year to May 2026. Annualised returns are +19.73% over 3 years and +9.52% over 5 years. Against its International Multi-Cap Value category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $172, against $174 for the category, and to $133 over one year, against $128. Volatility over the past three years was 13.24% a year. In the 12 months to May 2026 the fund lost a net $16.7M, and assets reached $696.21M.
CSVAX Growth of $100
What $100 invested in Columbia International Dividend Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Multi-Cap Value category average over the same months.
| Period | CSVAX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $133 | $128 |
| 3 years (Jun 2023 – May 2026) | $172 | $174 |
| 5 years (Jun 2021 – May 2026) | $158 | $160 |
| Since data start (Sep 2019 – May 2026) | $206 | $209 |
CSVAX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +16.17% |
| 1 year | +33.35% |
| 3 years (annualised) | +19.73% |
| 5 years (annualised) | +9.52% |
CSVAX Annual Returns
Calendar-year total returns of Columbia International Dividend Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +16.17% |
| 2025 | +31.04% |
| 2024 | +2.23% |
| 2023 | +18.08% |
| 2022 | −15.12% |
| 2021 | +13.51% |
| 2020 | +5.63% |
| 2019 (Sep–Dec) | +10.06% |
CSVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.7% | +7.5% | −9.2% | +7.4% | +4.0% | — | — | — | — | — | — | — |
| 2025 | +3.6% | +2.1% | +0.5% | +2.1% | +5.1% | +2.5% | −1.8% | +4.0% | +2.9% | +1.0% | +1.0% | +4.4% |
| 2024 | −1.6% | +2.6% | +3.6% | −2.8% | +5.1% | −2.0% | +1.8% | +2.8% | +0.8% | −4.0% | −0.4% | −3.2% |
| 2023 | +8.6% | −4.1% | +3.9% | +3.0% | −3.9% | +4.2% | +2.3% | −3.9% | −3.0% | −2.1% | +8.6% | +4.3% |
| 2022 | −1.2% | −4.7% | −0.9% | −5.7% | +3.0% | −9.0% | +3.4% | −5.9% | −9.4% | +4.3% | +14.8% | −2.4% |
| 2021 | −1.8% | +3.4% | +3.7% | +2.8% | +3.8% | −2.0% | −0.4% | +1.3% | −4.3% | +3.6% | −3.1% | +6.3% |
| 2020 | −2.9% | −8.2% | −12.9% | +7.9% | +2.9% | +0.6% | +4.6% | +2.9% | −2.5% | −4.4% | +14.2% | +6.4% |
| 2019 | — | — | — | — | — | — | — | — | +2.9% | +2.0% | +1.1% | +3.7% |
CSVAX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.24%
- 3-year Sharpe ratio: 1.15 (vs 4.5% risk-free rate)
- Best month: +8.58% (Nov 2023)
- Worst month: −9.23% (Mar 2026)
CSVAX Fund Flows
Monthly money in and out of Columbia International Dividend Income Fund, from SEC Form N-PORT.
- 12-month net flow: −$16.7M
- 12-month gross sales (incl. reinvestments): $64.6M
- Sales ÷ redemptions: 0.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $2.6M | $7.1M | −$4.5M |
| Apr 2026 | $2.5M | $6.5M | −$3.9M |
| Mar 2026 | $6.5M | $6.8M | −$248K |
| Feb 2026 | $4.1M | $8.1M | −$3.9M |
| Jan 2026 | $8.0M | $9.1M | −$1.1M |
| Dec 2025 | $17.7M | $8.0M | $9.6M |
| Nov 2025 | $2.3M | $5.0M | −$2.7M |
| Oct 2025 | $2.6M | $7.1M | −$4.6M |
| Sep 2025 | $8.3M | $5.6M | $2.6M |
| Aug 2025 | $1.5M | $4.7M | −$3.3M |
| Jul 2025 | $2.9M | $7.4M | −$4.5M |
| Jun 2025 | $5.7M | $5.9M | −$172K |
CSVAX Assets Under Management
Net assets of Columbia International Dividend Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $696.21M |
| 2026-02-28 | $699.12M |
| 2025-11-30 | $593.43M |
| 2025-08-31 | $576.35M |
| 2025-05-31 | $561.84M |
| 2025-02-28 | $532.84M |
| 2024-11-30 | $539.80M |
| 2024-08-31 | $574.63M |
| 2024-05-31 | $568.92M |
| 2024-02-29 | $555.97M |
| 2023-11-30 | $538.73M |
| 2023-08-31 | $541.42M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.